Jayanthi Lea
Associate Program Director · University of Texas Southwestern Medical Center
Credentials: · · · · ·
History
- Present
Department of Obstetrics and Gynecology · University of Texas Southwestern Medical Center
1996–1997Riverside Methodist Hospitals
Research
A STING-activating nanovaccine for cancer immunotherapy
Nature Nanotechnology · 2017 · 669 citations
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 486 citations
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Journal of the National Comprehensive Cancer Network · 2023 · 349 citations
45 papers
18 papers
18 papers · 10 as a fellow
- SK
16 papers
14 papers
14 papers
11 papers · 5 as a resident
11 papers
Grants
- 2022–2026
Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis
National Cancer Institute · R01
PI · $3.8M · Children's Hosp of Philadelphia
Clinical trials
- 2024–2027
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
Principal investigator · Recruiting · Phase 2
University of Texas Southwestern Medical Center
- 2019–2021
PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer
Principal investigator · Completed · Early phase 1
University of Texas Southwestern Medical Center
- 2012–2017
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Study chair · Terminated · Phase 1, Phase 2
South Plains Oncology Consortium
- 2008–2009
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
Study chair · Withdrawn · Phase 1, Phase 2
University of Texas Southwestern Medical Center